United States Prostrate Specific Antigen Testing Market Report 2017

February 2017 | 124 pages | ID: U23FDC51905EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Prostrate Specific Antigen Testing

Revenue, means the sales value of Prostrate Specific Antigen Testing

This report studies sales (consumption) of Prostrate Specific Antigen Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott Laboratories
• Bayer
• Beckman Coulter
• GE Helathcare
• GlaxoSmithKline
• Novartis Pharma
• UroLogix
• Bristol-Myers Squibb Company
• AstraZeneca
• Johnson & Johnson Diagnostics
• BioChem Pharma
• Pharmacia Delfia
• Roche Diagnostics
• Olympus
• Tosho

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Prostrate Specific Antigen Testing in each application, can be divided into

• Application 1
• Application 2

Contents

United States Prostrate Specific Antigen Testing Market Report 2017

1 PROSTRATE SPECIFIC ANTIGEN TESTING OVERVIEW

1.1 Product Overview and Scope of Prostrate Specific Antigen Testing
1.2 Classification of Prostrate Specific Antigen Testing
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Prostrate Specific Antigen Testing
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Prostrate Specific Antigen Testing (2012-2022)
  1.4.1 United States Prostrate Specific Antigen Testing Sales and Growth Rate (2012-2022)
  1.4.2 United States Prostrate Specific Antigen Testing Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROSTRATE SPECIFIC ANTIGEN TESTING COMPETITION BY MANUFACTURERS

2.1 United States Prostrate Specific Antigen Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Prostrate Specific Antigen Testing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Prostrate Specific Antigen Testing Average Price by Manufactures (2015 and 2016)
2.4 Prostrate Specific Antigen Testing Market Competitive Situation and Trends
  2.4.1 Prostrate Specific Antigen Testing Market Concentration Rate
  2.4.2 Prostrate Specific Antigen Testing Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PROSTRATE SPECIFIC ANTIGEN TESTING SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Prostrate Specific Antigen Testing Sales and Market Share by States (2012-2017)
3.2 United States Prostrate Specific Antigen Testing Revenue and Market Share by States (2012-2017)
3.3 United States Prostrate Specific Antigen Testing Price by States (2012-2017)

4 UNITED STATES PROSTRATE SPECIFIC ANTIGEN TESTING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Prostrate Specific Antigen Testing Sales and Market Share by Type (2012-2017)
4.2 United States Prostrate Specific Antigen Testing Revenue and Market Share by Type (2012-2017)
4.3 United States Prostrate Specific Antigen Testing Price by Type (2012-2017)
4.4 United States Prostrate Specific Antigen Testing Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROSTRATE SPECIFIC ANTIGEN TESTING SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Prostrate Specific Antigen Testing Sales and Market Share by Application (2012-2017)
5.2 United States Prostrate Specific Antigen Testing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROSTRATE SPECIFIC ANTIGEN TESTING MANUFACTURERS PROFILES/ANALYSIS

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Beckman Coulter
  6.3.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Beckman Coulter Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GE Helathcare
  6.4.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GE Helathcare Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis Pharma
  6.6.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Pharma Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 UroLogix
  6.7.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 UroLogix Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
  6.8.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol-Myers Squibb Company Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 AstraZeneca
  6.9.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 AstraZeneca Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson Diagnostics
  6.10.2 Prostrate Specific Antigen Testing Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Diagnostics Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 BioChem Pharma
6.12 Pharmacia Delfia
6.13 Roche Diagnostics
6.14 Olympus
6.15 Tosho

7 PROSTRATE SPECIFIC ANTIGEN TESTING MANUFACTURING COST ANALYSIS

7.1 Prostrate Specific Antigen Testing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostrate Specific Antigen Testing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostrate Specific Antigen Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostrate Specific Antigen Testing Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROSTRATE SPECIFIC ANTIGEN TESTING MARKET FORECAST (2017-2022)

11.1 United States Prostrate Specific Antigen Testing Sales, Revenue Forecast (2017-2022)
11.2 United States Prostrate Specific Antigen Testing Sales Forecast by Type (2017-2022)
11.3 United States Prostrate Specific Antigen Testing Sales Forecast by Application (2017-2022)
11.4 Prostrate Specific Antigen Testing Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostrate Specific Antigen Testing
Table Classification of Prostrate Specific Antigen Testing
Figure United States Sales Market Share of Prostrate Specific Antigen Testing by Type in 2015
Table Application of Prostrate Specific Antigen Testing
Figure United States Sales Market Share of Prostrate Specific Antigen Testing by Application in 2015
Figure United States Prostrate Specific Antigen Testing Sales and Growth Rate (2012-2022)
Figure United States Prostrate Specific Antigen Testing Revenue and Growth Rate (2012-2022)
Table United States Prostrate Specific Antigen Testing Sales of Key Manufacturers (2015 and 2016)
Table United States Prostrate Specific Antigen Testing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostrate Specific Antigen Testing Sales Share by Manufacturers
Figure 2016 Prostrate Specific Antigen Testing Sales Share by Manufacturers
Table United States Prostrate Specific Antigen Testing Revenue by Manufacturers (2015 and 2016)
Table United States Prostrate Specific Antigen Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prostrate Specific Antigen Testing Revenue Share by Manufacturers
Table 2016 United States Prostrate Specific Antigen Testing Revenue Share by Manufacturers
Table United States Market Prostrate Specific Antigen Testing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prostrate Specific Antigen Testing Average Price of Key Manufacturers in 2015
Figure Prostrate Specific Antigen Testing Market Share of Top 3 Manufacturers
Figure Prostrate Specific Antigen Testing Market Share of Top 5 Manufacturers
Table United States Prostrate Specific Antigen Testing Sales by States (2012-2017)
Table United States Prostrate Specific Antigen Testing Sales Share by States (2012-2017)
Figure United States Prostrate Specific Antigen Testing Sales Market Share by States in 2015
Table United States Prostrate Specific Antigen Testing Revenue and Market Share by States (2012-2017)
Table United States Prostrate Specific Antigen Testing Revenue Share by States (2012-2017)
Figure Revenue Market Share of Prostrate Specific Antigen Testing by States (2012-2017)
Table United States Prostrate Specific Antigen Testing Price by States (2012-2017)
Table United States Prostrate Specific Antigen Testing Sales by Type (2012-2017)
Table United States Prostrate Specific Antigen Testing Sales Share by Type (2012-2017)
Figure United States Prostrate Specific Antigen Testing Sales Market Share by Type in 2015
Table United States Prostrate Specific Antigen Testing Revenue and Market Share by Type (2012-2017)
Table United States Prostrate Specific Antigen Testing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostrate Specific Antigen Testing by Type (2012-2017)
Table United States Prostrate Specific Antigen Testing Price by Type (2012-2017)
Figure United States Prostrate Specific Antigen Testing Sales Growth Rate by Type (2012-2017)
Table United States Prostrate Specific Antigen Testing Sales by Application (2012-2017)
Table United States Prostrate Specific Antigen Testing Sales Market Share by Application (2012-2017)
Figure United States Prostrate Specific Antigen Testing Sales Market Share by Application in 2015
Table United States Prostrate Specific Antigen Testing Sales Growth Rate by Application (2012-2017)
Figure United States Prostrate Specific Antigen Testing Sales Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Beckman Coulter Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table GE Helathcare Basic Information List
Table GE Helathcare Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table GE Helathcare Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table Novartis Pharma Basic Information List
Table Novartis Pharma Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Pharma Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table UroLogix Basic Information List
Table UroLogix Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table UroLogix Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Company Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table Johnson & Johnson Diagnostics Basic Information List
Table Johnson & Johnson Diagnostics Prostrate Specific Antigen Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Diagnostics Prostrate Specific Antigen Testing Sales Market Share (2012-2017)
Table BioChem Pharma Basic Information List
Table Pharmacia Delfia Basic Information List
Table Roche Diagnostics Basic Information List
Table Olympus Basic Information List
Table Tosho Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostrate Specific Antigen Testing
Figure Manufacturing Process Analysis of Prostrate Specific Antigen Testing
Figure Prostrate Specific Antigen Testing Industrial Chain Analysis
Table Raw Materials Sources of Prostrate Specific Antigen Testing Major Manufacturers in 2015
Table Major Buyers of Prostrate Specific Antigen Testing
Table Distributors/Traders List
Figure United States Prostrate Specific Antigen Testing Production and Growth Rate Forecast (2017-2022)
Figure United States Prostrate Specific Antigen Testing Revenue and Growth Rate Forecast (2017-2022)
Table United States Prostrate Specific Antigen Testing Production Forecast by Type (2017-2022)
Table United States Prostrate Specific Antigen Testing Consumption Forecast by Application (2017-2022)
Table United States Prostrate Specific Antigen Testing Sales Forecast by States (2017-2022)
Table United States Prostrate Specific Antigen Testing Sales Share Forecast by States (2017-2022)